CN104017057B - 一种st2蛋白抑制剂多肽及其应用 - Google Patents
一种st2蛋白抑制剂多肽及其应用 Download PDFInfo
- Publication number
- CN104017057B CN104017057B CN201410293555.XA CN201410293555A CN104017057B CN 104017057 B CN104017057 B CN 104017057B CN 201410293555 A CN201410293555 A CN 201410293555A CN 104017057 B CN104017057 B CN 104017057B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- protein inhibitor
- cell
- inhibitor polypeptide
- uterus carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410293555.XA CN104017057B (zh) | 2014-06-27 | 2014-06-27 | 一种st2蛋白抑制剂多肽及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410293555.XA CN104017057B (zh) | 2014-06-27 | 2014-06-27 | 一种st2蛋白抑制剂多肽及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104017057A CN104017057A (zh) | 2014-09-03 |
CN104017057B true CN104017057B (zh) | 2016-08-24 |
Family
ID=51434100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410293555.XA Expired - Fee Related CN104017057B (zh) | 2014-06-27 | 2014-06-27 | 一种st2蛋白抑制剂多肽及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104017057B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001218871A1 (en) * | 2000-03-21 | 2001-10-03 | Takao Arai | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same |
BR112014001283A2 (pt) * | 2011-07-18 | 2017-02-21 | Critical Care Diagnostics Inc | métodos de tratamento de doenças cardiovasculares e prevenção da eficácia da terapia de exercício |
-
2014
- 2014-06-27 CN CN201410293555.XA patent/CN104017057B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104017057A (zh) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schmidt et al. | RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation | |
Soheili et al. | Monkeypox: virology, pathophysiology, clinical characteristics, epidemiology, vaccines, diagnosis, and treatments | |
Samarpita et al. | Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis | |
Hu et al. | Inhibition of the PD-1/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice | |
WO2016155673A1 (zh) | 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用 | |
CN110772636A (zh) | Gpr31抑制剂在制备治疗心脏缺血再灌注损伤及相关疾病药物中的应用 | |
Wang et al. | Polysaccharides from Enteromorpha prolifera ameliorate acute myocardial infarction in vitro and in vivo via up-regulating HIF-1α | |
CN109438542A (zh) | 一种新型强心苷类单体化合物及其在制备抗肿瘤药物中的用途 | |
Kaushic | The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract | |
CN104017057B (zh) | 一种st2蛋白抑制剂多肽及其应用 | |
WO2023160029A1 (zh) | 白术内酯i在制备预防和/或治疗宫颈癌的药物中的用途 | |
CN102228455B (zh) | 双联苄类化合物在制备抗炎药物中的应用 | |
CN104059130B (zh) | 关于st2蛋白抑制剂多肽及其应用 | |
CN104017055B (zh) | 一种关于st2蛋白抑制剂多肽及其应用 | |
Xu et al. | Interleukin-22 derived from cervical cancer-associated fibroblasts accelerates senescence of normal fibroblasts and promotes expression of tumorigenesis-related factors in HeLa cells | |
Zhou et al. | NOD1 expression elicited by iE-DAP in first trimester human trophoblast cells and its potential role in infection-associated inflammation | |
Wade | Pioneer of in vitro fertilization wins Nobel Prize | |
Weng et al. | TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro | |
Zhu et al. | The expression of overexpressed PTEN enhanced IR-induced apoptosis of myocardial cells. | |
CN104478822B (zh) | 一种治疗骨质疏松的药物组合物 | |
CN104017056B (zh) | St2蛋白抑制剂多肽及其应用 | |
Shi et al. | Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice | |
CN110013482A (zh) | 帕纳替尼在制备治疗流感病毒感染的药物中的应用 | |
WO2022110010A1 (zh) | 免疫激活剂、抗原和抗体在制备预防、治疗肿瘤产品中的应用 | |
CN100591656C (zh) | 一种羟基苯甲酸酐二聚体类化合物、制备方法及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Kang Wei Inventor after: Ma Qingxiang Inventor after: Li Guang Inventor after: Kang Kai Inventor after: Peng Yuping Inventor before: Luo Ruixue |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160701 Address after: 719000, 93, Yu Xi Road, Yulin hi tech Development Zone, Shaanxi, Yulin Applicant after: Yulin City First Hospital Address before: High tech Zone Suzhou city Jiangsu province 215000 Chuk Yuen Road No. 209 Applicant before: Suzhou Pu Luo Da Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20170627 |